NCT02758067View on ClinicalTrials.gov

Comparison of the Effectiveness of Brexpiprazole With That of Risperidone

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2016

Conditions
Schizophrenia
Interventions
DRUG

brexpiprazole

2- 4 mg/day, tablets, oral, 28-weeks

DRUG

risperidone

4-6 mg/day, tablets, oral, 28-weeks

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

H. Lundbeck A/S

INDUSTRY